Whole Blood and Blood Components (Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived)

STN: 125396
Proper Name: Whole Blood and blood components (Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived).
Tradename: N/A
Manufacturer: Stanford Blood Center
Indication:

• Treatment of COVID-19 in patients with immunosuppressive disease or receiving immunosuppressive treatment.

Product Information

• Whole Blood and Components Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived) COVID-19 Convalescent Plasma Circular of Information

Supporting Documents

• October 10, 2025 Approval Letter - Whole Blood and Components Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived)
• September 15, 2025 Clinical Review Memo - Whole Blood and Components Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived)